{"pageContent": "Objectives: To assess the long-term outcomes of patients with prostate cancer managed with intermittent androgen suppression (IAS) following their enrollment in an open, non-randomised feasibility study initiated 10 years ago.", "metaData": {"source": "Focal therapy as primary treatment for localized prostate cancer: definition, needs and future\nhttps://pubmed.ncbi.nlm.nih.gov/27882770/"}}